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Background: Outbreaks of respiratory disease, febrile illness and rash occurred in two adjoining rural communities 
of Imo State, Southeastern, Nigeria, at different times between 2006 and 2020. Laboratory investigation was carried 
out to determine the aetiological agent of the outbreak.                                    
Methodology: Oropharyngeal swabs were collected from 6 individuals showing symptoms of disease, within 3-4 days 
of appearance of rash. Venous blood samples were also collected from a total of 41 symptomatic persons, their 
contacts and individuals with resolved infections. Swabs were inoculated into Vero, HEp-2c, B95a and MDCK cell lines. 
Sera were analyzed using enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G and M to rubella and 
measles viruses, while immunofluorescence assay was used to detect Lassa fever virus immunoglobulins.  Descriptive 
data were analyzed using the Statistical Package for the Social Sciences (SPSS).      
Results: Four of the 6 (66.7%) swab samples showed viral activity or cytopathic effect characterized by clumping of 
cells in Vero cells while 2 (33.3%) in Hep-2c characterized by rounding up of cells. Thirty-nine (95.1%) sera were 
positive for measles IgG while 13 (31.7%) were positive for IgM. Thirty-six (87.8%) sera were positive for rubella 
IgG but none was positive for IgM. None of the sera was positive for Lassa fever virus IgG and IgM.                             
Conclusion: Measles virus was responsible for the outbreak among previously vaccinated population in the 
communities, while Rubella and Lassa fever viruses were excluded as the etiological agents of the outbreak. 
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Abstrait: 
Contexte: Des flambées de maladies respiratoires, de maladies fébriles et d'éruptions cutanées sont survenues dans 
deux communautés rurales voisines de l'État d'Imo, dans le sud-est du Nigéria, à des moments différents entre 2006 
et 2020. Une enquête en laboratoire a été menée pour déterminer l'agent étiologique de l'épidémie.          
Méthodologie: Des écouvillons oropharyngés ont été prélevés sur 6 individus présentant des symptômes de maladie, 
dans les 3 à 4 jours suivant l'apparition de l'éruption cutanée. Des échantillons de sang veineux ont également été 
prélevés sur un total de 41 personnes symptomatiques, leurs contacts et des personnes souffrant d'infections 
résolues. Des écouvillons ont été inoculés dans des lignées cellulaires Vero, HEp-2c, B95a et MDCK. Les sérums ont 
été analysés en utilisant un test immuno-enzymatique (ELISA) pour les immunoglobulines G et M contre les virus de 
la rubéole et de la rougeole, tandis que le test d'immunofluorescence a été utilisé pour détecter les immunoglobulines 




du virus de la fièvre de Lassa. Les données descriptives ont été analysées à l'aide du progiciel statistique pour les 
sciences sociales (SPSS).                                                      
Résultats: Quatre des 6 échantillons sur écouvillon (66,7%) ont montré une activité virale ou un effet cytopathique 
caractérisé par l'agglutination des cellules dans les cellules Vero, tandis que 2 (33,3%) dans Hep-2c étaient 
caractérisés par un arrondissement des cellules. Trente-neuf (95,1%) sérums étaient positifs pour les IgG contre la 
rougeole tandis que 13 (31,7%) étaient positifs pour les IgM. Trente-six (87,8%) sérums étaient positifs pour les IgG 
contre la rubéole, mais aucun n'était positif pour les IgM. Aucun des sérums n'était positif pour les IgG et IgM du 
virus de la fièvre de Lassa.                             
Conclusion: Le virus de la rougeole était responsable de l'épidémie parmi la population précédemment vaccinée dans 
les communautés, tandis que les virus de la rubéole et de la fièvre de Lassa ont été exclus comme agents étiologiques 
de l'épidémie. 
Mots clés: épidémies; IgG et IgM; Lignées cellulaires; Vaccination; Virus de la rougeole 
Introduction: 
 Emerging infectious diseases have been 
the most implicated in recent outbreaks, 
affecting human and animal lives in very 
negative ways, globally. Viruses survive only in 
living cells essentially to create more particles 
by replication, which involves taking over the 
host cell protein and genetic material – synthetic 
processes, to produce virus related nucleic acid 
and proteins as new viruses (1). If not curtailed, 
the spread of viral disease in a population may 
become extensive, and most viruses especially 
the enteroviruses are known to survive harsh 
environmental conditions. In endemic areas, 
viruses are continuously shed into the environ- 
ment and this can give rise to an outbreak once 
entrance is gained into a suitable host (2).  
 Most RNA viruses of the families; 
Orthomyxoviridae, Paramyxoviridae and Corona 
viridae have been implicated in viral disease 
outbreaks, with pandemic potentials. In humans 
especially, respiratory viruses are one of the 
most important causative agents of diseases 
causing acute respiratory infections (ARIs), 
particularly among children less than five years, 
often with high morbidity and mortality world- 
wide (3). The appearance of new diseases and 
syndromes as well as the resurgence of old ones 
can be associated to a large extent with 
ecological changes that favour increased vector 
densities, coupled with human activities that 
spread infectious agents and introduce them 
into areas where they had been absent (4). 
 Many viral infections and their emer- 
gence are brought about by a combination of 
factors which increase human exposure to viral 
pathogens (5). Some of these factors include 
human behaviours such as environmental 
changes, food production, socio-economic and 
demographic factors, health care delivery, travel 
and commerce (6). Ecological factors also play 
a tremendous role in disease distribution and 
these changes at one point or the other 
encourage migration of virus reservoirs (such as 
wild birds and bats) which transmit viral 
diseases to both humans and animals in their 
course of migration (7). Recurrence of epide- 
mics and pandemics of viral origin in a number 
of cases occur as a result of some other factors 
which may be genetic changes or mutation 
(variations) in the genome of viruses or adapta- 
tion to new hosts (8).   
 When a virus succeeds in establishing an 
infection in the host, a viral disease results 
through one of the following; destruction of the 
host cells (cytolytic effects), continuous 
production of virus by budding in which the virus 
maintains in a steady state with the host or a 
chronic and often fatal condition arises due to 
integration of viral genetic material into the 
genome of the host, leading to transformation 
of the host cells (8). An infection is a condition 
in which viruses, bacteria, fungi or parasites 
enter the body and cause a state of disease (9). 
They damage cells of the body by adhering to 
and damaging the cell walls, releasing toxic 
substances or causing allergic reactions (10).  
 Majority of viral disease outbreaks are 
linked to water as the source. Schuster and 
colleagues (11) analyzed waterborne outbreaks 
and impact of drinking water quality on public 
health disease burden, and found that many 
factors such as severe weather or climate 
change, close proximity to animal populations, 
treatment system malfunctions, poor mainte- 
nance and treatment practices were associated 
with the reported disease outbreaks resulting 
from drinking water supplies. Transmission of 
viral diseases is of public health importance. 
Direct and indirect contacts between humans 
and other vertebrates have resulted in serious 
outbreaks (12). It has been estimated that 60% 
of human infections are caused by viruses (13). 
 While some viruses show full spectrum 
of characteristics that identify them as infectious 
agents in most viral diseases, others do not. 
Hence, the aim of this outbreak investigation 
was to identify the etiological agent of the 
outbreaks in two rural communities of Imo 
State, Southeastern, Nigeria, with laboratory 
investigations including serological tests, virus 




isolation in cell lines, and immunofluorescent 
assays.                                             
 
Materials and method: 
 
Study area 
 This outbreak investigation was carried 
out in Obowu Local Government Area of Imo 
State, Nigeria. The area comprises of fourteen 
communities. It lies on longitude 7020'E and 
Latitude 5030'N. It is located about 150 km 
north of Bonny in Eastern Nigeria, with an 
estimated population of about 50,000 people as 
projected from the 2006 census figure (16). 
                         
Ethical consideration     
 Approval to investigate the outbreaks 
was obtained from the local councils and the 
traditional rulers of affected communities. 
Informed consent of all persons from whom 
samples were collected was obtained. 
Data collection and sample processing 
 Data from individuals including records 
of vaccination and other useful information 
regarding the outbreak, were collected. These 
included information on vaccination history, and 
symptoms observed such as sore throat, cough, 
catarrh, coryza, myalgia, fever. Oropharyngeal 
swab samples were collected from 6 persons 
presenting with fresh symptoms of rash and 
respiratory infection while venous samples were 
collected from a total of 41 persons with 
symptoms, their contacts and individuals with 
resolved infections.     
 The swab specimens were collected on 
swab sticks into sterile cryovials containing PBS 
and antibiotics as transport medium. The 
samples were preserved at -200C until trans- 
ported with ice packs to the laboratory for 
analysis. In addition, venous blood samples 
were collected into sterile EDTA bottles 
containing anticoagulant from all individuals 
including those with clinical symptoms, resolved 
cases and contacts of those with active disease 
and symptoms. The samples were stored at 40C 
until transported to the laboratory.  
 Both blood and oro-pharyngeal samples 
were transported to Virology laboratory of the 
University College Hospital, Ibadan, Nigeria, in 
insulated boxes containing ice-packs to maintain 
the cold chain. Blood samples were separated 
and sera stored in new sterile tubes and stored 
at -200C pending analyses. 
 
Virus isolation in tissue culture 
 Four cell lines were used for the primary 
isolation and ‘passage’ of the suspected viral 
agent from each swab sample. The cell lines 
included Vero (from African green monkey 
kidney), HEp-2c (derived from human epithelial 
cells), MDCK (Mardin-Darbin Canine Kidney 
cells) and B95a (from kidney of Marmoset 
Monkey). Each oro-pharyngeal swab sample 
was diluted and made up to 2.5 ml with mainte- 
nance medium and filtered using a 0.2µl milli- 
pore filter into new set of pre-labelled Kahn 
tubes. After filtration, 0.2ml of each swab 
sample was inoculated into each cell line after 
decanting the growth medium. Virus from 
sample was allowed to adsorb at 370C for one 
hour, and the appropriate maintenance medium 
was added to each cell line. The medium of cell 
control tubes was replaced with maintenance 
medium.  
 All the tubes were incubated at 370C and 
examined daily for evidence of virus growth 
(cytopathic effect) for seven days. Tubes 
showing cytopathic effects (CPE) on or before 
the seventh day were passed into new culture 
tubes to rule out toxicity or to increase the virus 
titre. Similarly, tubes without obvious CPE were 
also re-passaged. Any culture tubes without CPE 
after the first blind ‘passage’ and kept for more 
days were regarded as negative. The tubes 
showing cytopathic effects (CPE) were passed 
up to four times into 25cm3 culture flasks to 
increase the virus titre and yield. The super- 
natant fluid of each flask was collected and 
stored in aliquots at -80oC for further analysis. 
 
Detection of Measles immunoglobulin G & M  
 Measles IgG and M was detected using 
Orgenics ImmunolisaTM kit. All the reagents and 
samples were allowed to attain room tempe- 
rature on the bench. The incubator was set at 
370C. The microplate R1 was labelled with 
sample numbers accordingly, including the four 
control wells. Then, 100µl of serum dilution 
solution R2 was added into all the wells and 5µl 
of each sample into appropriate wells. Also, 5µl 
of positive control R3 and 5µl of cut off serum 
R5 were added in duplicate, and 5µl of negative 
control was dispensed. The microplate was 
covered with sealing sheet and incubated at 
370C for 45mins. After incubation, 100µL of 1gG 
conjugate solution R9 was immediately added 
into each well. The microplate was sealed again 
and incubated at 370C for 30min. This was 
followed by washing of the plate with 0.3ml of 
washing solution R13. 100 µl of substrate 
solution R11 was added into each well. The plate 
was sealed and incubation done at room 
temperature for 20mins. The seal was removed 
and 50µl of stopping solution R12 added into all 
the wells. Reading of the plate was carried out 
with a spectrophotometer at 450/620nm. 
 The mean OD (Optical Density) for each 




control (positive, negative and cut off) was 
calculated as; cut off control = < 0.7 x (OD 
Positive Control)/>1.5 x (OD Negative Control), 
and antibody index = sample OD/cut off serum 
mean OD x 10. For validity of the result, OD for 
positive control must be > 0.9 while that of 
negative control must be < 0.55. The antibody 
index for positive samples was > 11 while that 
of negative samples was < 9. Samples with IgG 
and IgM index values of 9 - 11 were equivocal. 
Hence, samples with index values above 11 are 
considered as having IgG or IgM specific 
antibodies against measles, and the final result 
was based on these values.   
 
Determination of Rubella immunoglobulin G & 
M by IgM ‘capture’.  
 Using the Dia-Pro Diagnostic Bioprobes 
serological reagents, samples were diluted in 
ratio 1:101 with the sample diluent (10µl 
sample + 1000µl diluent) and dispensed accor- 
dingly. Ninety-six well microplate was covered 
with a sealer and incubated for 60min at 370C. 
Then 100µl of diluted Ag/Ab (immune complex) 
was added to all well except A1.  The plate was 
incubated at 370 C for 60min. After removing the 
sealer, the microplate was washed five times 
using the automatic washer. This was followed 
by addition of 100µl of the chromogen/substrate 
mixture into the wells, A1 included. The plate 
was incubated the third time at room tempe- 
rature for 20min.100µl stop solution was added 
to all wells, A1 included. The Microplate was 
read at 450nm and 620-630nm, blanking the A1 
well.  
 
Detection of Lassa fever immunoglobulin G & M 
by immunofluorescence assay (IFA)                                                                                                                                                                                                                                                                                                                               
 The IFA slides and samples were allowed 
to attain room temperature before use. Samples 
were diluted in ratio 1:40 by adding 5µl of each 
serum sample into 195µl of PBS in a pre-labeled 
microplate. Then, 20µl of 1:40 dilution of speci- 
men was dispensed accordingly into the wells of 
the slides. Controls were dispensed into the 
corresponding wells. The IgM slides were placed 
in a tray and incubated at 37oC in humidified 
chamber for 2 hours while IgG slides were 
incubated for one hour. After incubation, slides 
were flooded with PBS and rocked for 10min on  
a rocker. Both slides were air dried and 
respective Fluorescein isothiocyanate (FITC) 
conjugated-sheep antihuman Ig (Murex Diag- 
nostic Ltd., Dartford, England) added into all the 
wells. The second incubation was carried out at 
370C for 30min.Slides were flooded and washed 
for another 10min on a rocker. After washing, 
each slide was covered with a cover slip and 
slides mounted on the fluorescence microscope 
for microscopic examination.   
 
Statistical analysis  
 Descriptive data were analyzed using 




 In the two affected rural communities, 
41 persons were serologically investigated, 14 
(34.1%) males and 27 (65.9%) females, all 
aged between 3 months and 50 years. Six 
(14.6%) had clinical symptoms at the time of 
the outbreak investigation; 28 (68.3%) had 
resolved symptoms while 7 (17.1%) contacts 
reported no symptoms. Forty (97.6%) were 
previously vaccinated while 1 (2.4%) was yet to 
be vaccinated.  
 Of the 6 oropharyngeal swab samples, 4 
(66.7%) showed evidence of viral growth 
(clumping of infected cells) in Vero, 2 (33.3%) 
samples showed CPE (rounding up of cells) in 
HEp-2c, and none in B95a and MDCK cell lines. 
This confirmed that virus was implicated in the 
outbreak. Serum samples of 39 (95.1%) out of 
41 subjects were positive for measles IgG as 
shown in Fig 1. Fig 2 shows the distribution of 
measles IgM in which 13 (31.7%) were positive, 
12 (92.3%) of whom were positive for both IgG 
and IgM. Figs 2, 3 and 4 show the number and 
percentage of positive results within different 
age groups and gender of the subjects. 
 Out of the 41 venous blood serum 
samples, 36 (87.8%) were positive for Rubella 
IgG. Fig 5 shows the distribution of Rubella IgG 
result among 13 (36.1%) males and 23 (63.9%) 
females.  All sera were negative for rubella IgM. 
Furthermore, all samples tested negative for 
both IgG and IgM to Lassa fever virus. Hence, 
rubella and Lassa fever viruses were ruled out 
as the aetiological agents of the outbreak. 
 













































































 Measles remains a serious global health 
challenge, which has persisted even with the 
availability of a vaccine. It is highly contagious, 
with increased morbidity and mortality, espe- 
cially among children less than five years of age. 
Measles virus is an enveloped, ribonucleic acid 
virus (RNA) of the genus Morbillivirus and family 
Paramyxoviridae. There are more than 20 diffe- 
rent genotypes that have been isolated in 
various parts of the world, but with only one 
serotype (9). In Nigeria, measles, mumps and 
rubella (MMR) vaccines are given through 
compulsory routine vaccination exercise to 
infants at nine months of age (17). It is 
noteworthy, that this outbreak occurred among 
vaccinated subjects in those communities as 
shown by the positive measles IgG results. 
Measles outbreak among vaccinated children 
and adults rather poses some questions that 
require urgent scientific explanation.  
 Rubella virus was excluded as the 
causative agent of the outbreak, because none 
of the samples was positive for rubella IgM, 
however, 87.8% tested positive for IgG. These 
individuals (both gender) in the past received 
MMR vaccine, which may be responsible for 
rubella IgG antibody response. The same 
vaccination was supposedly responsible for the 


























Fig 4: Age Range of Subjects Positive to Measles IgM


























Fig 5: Subjects Positive to Rubella IgG
Male Female




population.     
 In the outbreak, both male and female 
subjects were infected with measles virus, 
although more females (76.9%) than males 
(32.1%) had active measles (Fig 3) and these 
subjects fell in the age range 0-50years, with 
more measles IgG level (46.2%) among those 
aged 11-20 years (Fig 4), and highest IgM level 
among age groups 11-20 and 21-30 years 
respectively (Fig 5). Forty (97.6%) had been 
vaccinated previously, except 1 (2.4%), a 3-
month-old baby, yet to receive MMR routine 
immunization. Those infected had symptoms 
including febrile illness (high fever), cough, 
coryza (runny nose), red watery eyes and 
maculopapular rash which appeared last in most 
cases.      
 Immunity conferred by measles through 
natural infection and vaccination is apparently 
long-lasting, but some cases of atypical measles 
have been reported in adolescents who had 
been vaccinated as children (14,15). This 
suggests that immunity in the vaccinated 
population may have waned and therefore not 
as long-lasting as that following natural 
infection. It could also mean circulation of a 
different strain of the measles virus in the 
population, to which people have little or no 
immunity. However, it would be potentially 
serious, if vaccination in children left some 
people unprotected in teenage and adult life.  
 Furthermore, among the subjects who 
showed evidence of measles infection in this 
investigation, six presented with clinical acute 
respiratory symptoms and maculopapular rash 
and they all had positive measles IgM results. 
Three individuals who tested positive for 
measles IgM had resolved symptoms, while 4 
were part of the 7 contacts who showed no 
symptom as at the time of sample collection. 
This suggests that these exposed individuals 
(contacts)contracted the virus and could be 
incubating it at the time of sample collection, 
owing to the contagious nature of measles virus.
 Measles is known as a childhood disease 
(4) but its occurrence twice or more times in a 
vaccinated population, as seen in this investi- 
gation including adults, requires urgent atten- 
tion.  Measles virus infection remains a serious 
global health problem. Cases of infection caused 
by wild strain of measles virus in previously 
vaccinated subjects have been documented (2). 
As this trend persists, there is need for increased 
global campaign and awareness on the impor- 
tance of booster vaccination especially among 
teenagers and adults who were vaccinated at 
infancy. This may be one sure way to prevent 
future measles outbreaks and ensure its 
eradication in the globe. 
Conclusion:   
 In conclusion, the cytopathic effects 
(CPE) on cell cultures implicated virus as the 
aetiologic agent of the outbreak of an infectious 
respiratory disease and rashes in the two 
adjoining communities of Obowu LGA of Imo 
State, Nigeria. Further serological investigation 
confirmed measles virus as the cause of the 
outbreak as indicated by positive IgM antibodies 
in the infected subjects, which confirmed recent 
and active infection.  
Acknowledgements: 
 
 The authors acknowledge the staff of 
Department of Virology and other public health 
officials who assisted during sample collection 
and analysis of samples.   
 
Conflict of interest: 
 




1.  Alan, J. C. Virus structure and replication: In: 
 Molecular Virology (2nd ed). Academic Press, 
 Harcourt Brace and Company, 1997; 1-49. 
 2.  Centre for Disease Control and Prevention (CDC). 
 Mumps epidemic Iowa MMWR Morb Mortal Wkly 
 Rep. 2006; 55 (13): 366-368.                         
3.   Nichols, W. G., Peck Campbell, A. J., and Boeckh, 
 M. Respiratory viruses other than influenza virus: 
 impact and therapeutic advances. Clin Microbiol 
 Rev. 2008; 21 (2): 274–290.                         
4.  Chen, R. T., Goldbaum, G. M., and Wassilak, S. G. 
 F. An explosive point-source measles outbreak in a 
 highly vaccinated population: Mode of transmission 
 and risk factors for disease. Am J Epidemiol. 1989; 
 129: 173-182.                               
5.  Morse, S. S. Factors in the emergence of infectious 
 diseases. Emerg Infect Dis. 1995; 1 (1): 7–15                 
6.  Gratz, N. G.  Emerging and resurging vector-borne 
 diseases. Annu Rev Entomol. 1999; 44: 51-75.                      
7.  Melville, D. S., and Shortridge, K. F. Spread of 
 H5N1, avian influenza virus: an ecological 
 conundrum. Lett Appl Microbial. 2006; 42 (5): 435-
 437.                              
8.  Nugeut, J., Birch-Machin, I., Smith, K. C., et al. 
 Analysis of equid herpes virus 1 strain variation 
 reveals a point mutation of the DNA polymorphism 
 strongly associated with neuropathogenic versus 
 non-neuropathogenic disease outbreaks. J Virol. 
 2006; 80 (8): 4047-4060.                             
9.  World Health Organizations. Biological; Measles 
 https://www.who.int/biologicals/vaccines/measles/
 en/. 11 March 2013.                      
10.  Cheesbrough, M. Medical Laboratory Manual for 
 Tropical Countries. Vol 2. ELBS London, 2007.                        
11.  Schuster, C. J., Ellis, A. G., Robertson, W. J., et al. 
 Infectious disease outbreaks related to drinking 
 water in Canada, 1974 – 2001. Can J Publ Hlth. 
 2005; 96 (4); 254- 258.                       
12.  Turbeville, S. D., Cowan, L. D., and Greenfield, R. 
 A. Infectious Disease Outbreak in Competitive 
 Sports: A Review of Literature. Am J Sports Med. 
 2006; 34 (11): 1860-1865.   
 doi: 10.1177/0363546505285385                        




13.  Vesperman, J. Revision History. The Gale group Inc. 
 gale, Detroit Gale Encyclopedia of Nursing and 
 Allied Health, 2002.                         
14.  Wong, R. D., Goetz, M. B., Mathisen, G., et al. 
 Clinical and laboratory features of measles in 
 hospitalized adults. Am J Med. 1993; 95: 377-383. 
15.  Davidkin, S., Jokinen, M., Broman, P., et al. Persis-
































  tence of measles, mumps, and rubella antibodies 
 in an MMR-vaccinated cohort: a 20-year follow-up 
 J Infect Dis. 2008; 197 (7): 950-956                      
16.  National Population Commission. Nigeria National 
 Census, 2006.                                         
17.   World Immunization Chart. Updated December, 
 2020. www.iamat.org. 
